Two applications of macrocyclic small molecules in cancer therapy (IMAGE)
Caption
Two applications in cancer therapy include: 1) as cancer drugs to target proteins critical in cancer formation or progression for nearly 80% hallmarks of cancer; 2) as cancer drugs to target resistant mutations to overcome drug resistance in targeted therapy, such as EGFR, ALK, ROS1, and TRKA mutants.
Credit
Beijing Zhongke Journal Publising Co. Ltd.
Usage Restrictions
Marked by the credited
License
Licensed content